Results 31 to 40 of about 5,855 (210)
Update on Anxiolytics and Hypnotics [PDF]
Goal The goal of this article is to educate pharmacists on the new er anxiolytic and hypnotic agents. Objectives After reading this article, the pharmacist shouid be able to: • Discuss the advantages of the new hypnotics and anxiolytics over previous ...
Gutierrez, Mary +2 more
core +1 more source
Using anxiolytics in epilepsy: neurobiological, neuropharmacological and clinical aspects. [PDF]
Anxiety disorders represent a common psychiatric comorbidity in patients with epilepsy, affecting prognosis and quality of life. However, they are still underdiagnosed and undertreated.
Mula, M, Marco Mula
core +1 more source
Considering the allosteric regulation of mGlu receptors for potential therapeutic applications, we developed a group of 1,2,4-oxadiazole derivatives that displayed mGlu4 receptor positive allosteric modulatory activity (EC50 = 282–656 nM).
Anna Stankiewicz +12 more
doaj +1 more source
An update on the pharmacological treatment of anxiety and related disorders
The anxiety disorders, obsessive compulsive disorder (OCD) and post-traumatic stress disorder (PTSD) are common and debilitating, often coexist with medical and psychiatric conditions, and usually require long-term treatment.
K. Outhoff
doaj +1 more source
Utilization of antidepressants, anxiolytics, and hypnotics during the COVID-19 pandemic in Scandinavia [PDF]
OBJECTIVE: To study patterns of antidepressant, anxiolytic, and hypnotic drug utilization in Denmark, Norway, and Sweden during the first year of the COVID-19 pandemic.
Wesselhoeft, Rikke; id_orcid +26 more
core +1 more source
Childhood anxiety disorders are traditionally treated with selective serotonin reuptake inhibitors (SSRIs). Other anxiolytics, including benzodiazepines, antihistamines, and buspirone are also used to treat anxiety and sleep disorders in youth ...
Coffey, Barbara J +3 more
core +1 more source
Anxiolytics: past, present, and future agents
Although anxiety disorders were classified as neurotic disorders and not systematically studied before DSM-III, researchers and clinicians have been searching for effective, safe agents to treat anxiety symptoms and disorders for over a century.
Nemeroff, Charles B
core +2 more sources
Anxiolytics (N05B) are one of the most widely used pharmacological groups. This study aimed to analyze the progression of the consumption of anxiolytics (ATC classification: N05B) dispensed in pharmacies in Castile and Leon, Spain, from 2015 to 2020 ...
María Luisa Martín-Calvo +2 more
core +1 more source
Boundary‐Dependent Sleep–Wake Dysregulation in Idiopathic Hypersomnia
ABSTRACT Objective Idiopathic hypersomnia (IH) presents with excessive daytime sleepiness (EDS) despite apparently preserved nocturnal sleep, challenging traditional models of hypersomnolence based on sleep loss or fragmentation. We aimed to test the hypothesis that EDS in IH reflects excessive stabilization of the sleep state, consistent with ...
Samantha Mombelli +13 more
wiley +1 more source
PRESCRIBING CHANGES IN ANXIOLYTICS AND ANTIDEPRESSANTS IN SLOVENIA [PDF]
Background: The ratio of anxiolytics to antidepressants is an indicator of the quality of treatment of depression and anxiety in primary care. The objective of the study was to investigate the prescription of anxiolytics and antidepressants among ...
Vidmar, Gaj, Šubelj, Maja, Švab, Vesna
core +1 more source

